BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 18515242)

  • 1. Second cancers in survivors of hodgkin lymphoma: risks and recommendations.
    Leahy Y
    Clin J Oncol Nurs; 2008 Jun; 12(3):437-42. PubMed ID: 18515242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognizing health risks in childhood cancer survivors.
    Nelson MB; Meeske K
    J Am Acad Nurse Pract; 2005 Mar; 17(3):96-103. PubMed ID: 15748222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular late effects.
    Greving DM; Santacroce SJ
    J Pediatr Oncol Nurs; 2005; 22(1):38-47. PubMed ID: 15574725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
    De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
    J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survivorship care: models and programs.
    McCabe MS; Jacobs L
    Semin Oncol Nurs; 2008 Aug; 24(3):202-7. PubMed ID: 18687266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term complications following treatment of testicular cancer and Hodgkin lymphoma].
    van den Belt-Dusebout AW; Aleman BM; Gietema JA; de Wit R; van 't Veer MB; Lugtenburg PJ; Krol AD; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2010; 154(45):A2229. PubMed ID: 21118593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hodgkin lymphoma: the follow-up of long-term survivors.
    Hodgson DC
    Hematol Oncol Clin North Am; 2008 Apr; 22(2):233-44, vi. PubMed ID: 18395147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
    Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
    J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic radiation for lymphoma: risk of malignant mesothelioma.
    Teta MJ; Lau E; Sceurman BK; Wagner ME
    Cancer; 2007 Apr; 109(7):1432-8. PubMed ID: 17315168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based study of follow-up care for Hodgkin lymphoma survivors: opportunities to improve surveillance for relapse and late effects.
    Hodgson DC; Grunfeld E; Gunraj N; Del Giudice L
    Cancer; 2010 Jul; 116(14):3417-25. PubMed ID: 20564062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late effects of Hodgkin's disease and its treatment.
    Ng AK; Mauch PM
    Cancer J; 2009; 15(2):164-8. PubMed ID: 19390314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical practice guidelines for the use of colony-stimulating factors in cancer treatment: Implications for oncology nurses.
    Kearney N; Friese C
    Eur J Oncol Nurs; 2008 Feb; 12(1):14-25. PubMed ID: 18291720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline.
    Landier W; Bhatia S; Eshelman DA; Forte KJ; Sweeney T; Hester AL; Darling J; Armstrong FD; Blatt J; Constine LS; Freeman CR; Friedman DL; Green DM; Marina N; Meadows AT; Neglia JP; Oeffinger KC; Robison LL; Ruccione KS; Sklar CA; Hudson MM
    J Clin Oncol; 2004 Dec; 22(24):4979-90. PubMed ID: 15576413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing a survivorship care plan for patients with breast cancer.
    Miller R
    Clin J Oncol Nurs; 2008 Jun; 12(3):479-87. PubMed ID: 18515246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subsequent malignant neoplasms in cancer survivors.
    Ng AK; Travis LB
    Cancer J; 2008; 14(6):429-34. PubMed ID: 19060610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere shortening and associated chromosomal instability in peripheral blood lymphocytes of patients with Hodgkin's lymphoma prior to any treatment are predictive of second cancers.
    M'kacher R; Bennaceur-Griscelli A; Girinsky T; Koscielny S; Delhommeau F; Dossou J; Violot D; Leclercq E; Courtier MH; BĂ©ron-Gaillard N; Assaf E; Ribrag V; Bourhis J; Feneux D; Bernheim A; Parmentier C; Carde P
    Int J Radiat Oncol Biol Phys; 2007 Jun; 68(2):465-71. PubMed ID: 17418962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facilitating care for childhood cancer survivors: integrating children's oncology group long-term follow-up guidelines and health links in clinical practice.
    Eshelman D; Landier W; Sweeney T; Hester AL; Forte K; Darling J; Hudson MM
    J Pediatr Oncol Nurs; 2004; 21(5):271-80. PubMed ID: 15381795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatigue in women receiving intraperitoneal chemotherapy for ovarian cancer: a review of contributing factors.
    Anderson NJ; Hacker ED
    Clin J Oncol Nurs; 2008 Jun; 12(3):445-54. PubMed ID: 18515243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are we improving the long-term burden of Hodgkin's lymphoma patients with modern treatment?
    Aleman BM; van Leeuwen FE
    Hematol Oncol Clin North Am; 2007 Oct; 21(5):961-75. PubMed ID: 17908631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer overview.
    Ely S; Vioral AN
    Plast Surg Nurs; 2007; 27(3):128-33; quiz 134-5. PubMed ID: 17901821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.